News ESMO26: Takeda preps filings on CLDN18.2 gastric cancer data Takeda and Innovent's CLDN18.2-targeting ADC, arcotatug tavatecan, will be filed in Japan on the back of positive survival data in gastric cancer.
News ESMO26: Tango sees 82% ORR with combo in pancreatic cancer A study of RevMed's Rasonque with Tango's vopimetostat has raised hopes of a new combination therapy for aggressive pancreatic cancer.
News ESMO26: Moderna, MSD reveal cancer jab data early after leak Moderna and MSD shared the results for their melanoma cancer vaccine trial, ahead of a presentation at ESMO tomorrow, after a data breach.
News Clinical trial setup times fall sharply in UK Reforms to the regulatory framework for clinical research in the UK are starting to deliver, with delivery times down 35%, according to new data.
News UK trial 'could halve time to test Alzheimer's drugs' A pioneering UK study, AD-SMART, will test multiple repurposed and new drugs in parallel to try to slash the time it takes to gauge their efficacy.
News CagriSema helps women lose 25% of their weight in study Novo continues to build the case for its new weight-loss candidate CagriSema, pointing to new data that show strong efficacy in women.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.